Anti-TRIM71 monoclonal antibody

Pre-made anti-TRIM71 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRIM71/TRIM71 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2781-Ab-1/ GM-Tg-hg-IP2781-Ab-2Anti-Human TRIM71 monoclonal antibodyHuman
GM-Tg-rg-IP2781-Ab-1/ GM-Tg-rg-IP2781-Ab-2Anti-Rat TRIM71 monoclonal antibodyRat
GM-Tg-mg-IP2781-Ab-1/ GM-Tg-mg-IP2781-Ab-2Anti-Mouse TRIM71 monoclonal antibodyMouse
GM-Tg-cynog-IP2781-Ab-1/ GM-Tg-cynog-IP2781-Ab-2Anti-Cynomolgus/ Rhesus macaque TRIM71 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2781-Ab-1/ GM-Tg-felg-IP2781-Ab-2Anti-Feline TRIM71 monoclonal antibodyFeline
GM-Tg-cang-IP2781-Ab-1/ GM-Tg-cang-IP2781-Ab-2Anti-Canine TRIM71 monoclonal antibodyCanine
GM-Tg-bovg-IP2781-Ab-1/ GM-Tg-bovg-IP2781-Ab-2Anti-Bovine TRIM71 monoclonal antibodyBovine
GM-Tg-equg-IP2781-Ab-1/ GM-Tg-equg-IP2781-Ab-2Anti-Equine TRIM71 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2781-Ab-1/ GM-Tg-hg-IP2781-Ab-2; GM-Tg-rg-IP2781-Ab-1/ GM-Tg-rg-IP2781-Ab-2;
GM-Tg-mg-IP2781-Ab-1/ GM-Tg-mg-IP2781-Ab-2; GM-Tg-cynog-IP2781-Ab-1/ GM-Tg-cynog-IP2781-Ab-2;
GM-Tg-felg-IP2781-Ab-1/ GM-Tg-felg-IP2781-Ab-2; GM-Tg-cang-IP2781-Ab-1/ GM-Tg-cang-IP2781-Ab-2;
GM-Tg-bovg-IP2781-Ab-1/ GM-Tg-bovg-IP2781-Ab-2; GM-Tg-equg-IP2781-Ab-1/ GM-Tg-equg-IP2781-Ab-2
Products NameAnti-TRIM71 monoclonal antibody
Formatmab
Target NameTRIM71
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRIM71 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2781-Ag-1Recombinant multi-species LIN41/ TRIM71/ LIN-41 protein


    Target information

    Target IDGM-IP2781
    Target NameTRIM71
    Gene ID131405,636931,301042,705341,477014,101096006,531886,100056593
    Gene Symbol and Synonyms2610206G21Rik,Gm1127,HYC4,HYDCC1,LIN-41,LIN41,mlin-41,mLin41,RGD1566388,TRIM71
    Uniprot AccessionQ2Q1W2,D3ZVM4,E1BJS7
    Uniprot Entry NameLIN41_HUMAN,LIN41_RAT,LIN41_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000206557
    Target ClassificationN/A

    The target: TRIM71, gene name: TRIM71, also named as LIN-41, LIN41. The protein encoded by this gene is an E3 ubiquitin-protein ligase that binds with miRNAs and maintains the growth and upkeep of embryonic stem cells. This gene also is involved in the G1-S phase transition of the cell cycle. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.